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PURPOSE. Keratoconus is a heterogeneous disease associated with a range of pathologies,
including disorders that involve proteoglycans (PGs). Some PG alterations, mainly in keratan
sulfate (KS), occur in keratoconus. In this article, we studied the differential expression of the
genes encoding PGs in cells isolated from keratoconus patients and healthy controls, as well
as in corneal sections.
METHODS. Human central corneal tissue was obtained from cadaver donors and patients
undergoing penetrating keratoplasty surgery. A transcriptomic approach was used, employing
quantitative PCR, to analyze both the expression of the enzymes involved in glycosamino-
glycan (GAG) biosynthesis and the PG core proteins. The expressions of the differentially
expressed core proteins and of the GAG chains were also analyzed by immunocytochemistry
in the cultured cells, as well as by immunohistochemistry in corneal sections.
RESULTS. The mRNA levels of most major matrix PG mRNAs in the cultured keratoconic
stromal cells decreased except collagen XVIII, which increased. At keratocyte surfaces, some
heparan sulfate PGs were down-regulated. With respect to GAGs, there were changes in gene
expression for the polymerization of the GAG chains, mainly KS and chondroitin sulfate, and
in the modification of the saccharidic chains, pointing to an alteration of the sulfation patterns
of all GAG species.
CONCLUSIONS. Most of the PG core proteins underwent significant changes in cultured
keratoconic cells and corneas. With regard to GAG chains, the polymerization of the chains
and their chemical modification was modified in way that depended on the specific type of
GAG involved.
Keywords: keratoconus, proteoglycan, glycosaminoglycan, keratan sulfate, chondroitin
sulfate, heparan sulfate
Keratoconus is a corneal ectasia that displays many abnormalfeatures affecting different layers of the cornea.1–3
Keratoconus frequently occurs in isolation, but it is often
associated with a wide range of ocular disorders, including
various chromosomal abnormalities and connective tissue
disorders.2,4,5
The central stroma constitutes 90% of the corneal thickness
and consists of an extracellular matrix (ECM) interspersed with
keratocytes. The corneal stroma is composed primarily of
collagen fibrils that are coated by different proteoglycans
(PGs).6 Proteoglycans are a diverse group of glycoconjugates
composed of various core proteins posttranslationally modified
with anionic polysaccharides called glycosaminoglycans
(GAGs) such as chondroitin sulfate/dermatan sulfate (CS/DS),
keratan sulfate (KS), and heparan sulfate (HS). There are five
major PGs located in the corneal ECM; three of them, lumican,
keratocan, and osteoglycin, are KS PGs, whereas decorin and
biglycan are CS PGs.7,8 Moreover, keratinocytes express HS
PGs, which are ubiquitously present in tissues.9–11
Various eye diseases are related to changes in PGs, such as
the reduction of highly sulfated KS levels associated with
corneal pathologies and inflammatory conditions.12–14 A
progressive opacification of the cornea is characteristic of
some mucopolysaccharidosis.15,16 Moreover, at least two
corneal dystrophies, cornea plana and macular corneal
dystrophy, result from the failure of normal KS production.17,18
There are few studies examining alterations in corneal PGs
and GAGs in connection with keratoconus. With respect to PG
core proteins, biochemical approaches have identified hetero-
geneity in both CS/DS PGs and KS PGs, although the samples
analyzed in these studies included other diseases besides
keratoconus.19,20 More recently, analysis of the keratoconus
corneal proteome showed a decrease in lumican, decorin,
biglycan, and keratocan.1 In terms of GAG chains, it has been
described as an accumulation of GAG polyanions in keratoconic
corneas.21 However, in the central, thinned region of the
keratoconic cornea, the KS antigenicity is decreased,19 and in
severe keratoconic corneas, KS organization is markedly
different from that of controls.22 Interestingly, some connective
tissue disorders that appear in association with keratoconus
also involve molecular alterations in PGs.23–25
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In this study, we analyzed for the first time the differential
expression of PGs by stromal cells from keratoconic and normal
corneas. The study covers the genes encoding the PG core
proteins and the enzymes involved in the biosynthesis of the
GAG chains. We then examined keratoconic and normal corneas
by immunohistochemistry to analyze the core proteins and GAG
chains that were differentially expressed by the cultured cells.
PATIENTS AND METHODS
Tissue Samples
All of the corneas used in this study were obtained from the
Instituto Oftalmolo´gico Ferna´ndez-Vega (IOFV, Oviedo, Spain)
and from the Central University Hospital of Asturias (HUCA,
Asturias, Spain). Informed oral and written consent of the
patients was obtained, in accordance with the guidelines of the
Tenets of the Declaration of Helsinki.
Isolation and Culture of Corneal Stromal Cells
Human central corneal tissue was obtained from cadaver donors
and from penetrating keratoplasty interventions on patients
suffering from keratoconus. Healthy donor tissues were
screened and tested negative for HIV, hepatitis B and C viruses,
and syphilis and were not usable for human corneal transplan-
tation.
The epithelium was removed with ethanol (70%, 30
seconds) and a spatula, and the endothelium by Descemet
membrane endothelial keratoplasty, after which the absence of
epithelial and endothelial cells was assessed by microscopy.
Corneal stromal cells were obtained by digesting 2-mm-
diameter pieces from the central cornea in 0.25% trypsin/
EDTA solution for 30 minutes at 378C. After centrifugation, the
supernatant was discarded, and the pellet was resuspended in
a Dulbecco’s modified Eagle’s medium þ F12 culture medium
containing nonessential amino acids, RPMI 1640 Vitamin
Solution 1003, 1% antibiotics (penicillin/streptomycin), and
10% fetal bovine serum (Gibco, Waltham, MA, USA). When
cultures reached 80% confluence, they were replated at a
density of 2 3 105 cells/mL in 75-cm2 flasks. As a control to
evaluate if the cells maintained a stable phenotype, we
performed a-smooth muscle actin (SMA) immunostaining.
Smooth muscle actin staining remained negative at least until
the fifth passage, suggesting that the stromal cells did not
readily differentiate to myofibroblasts. As a result, only cultures
in passages 1 through 5 were used. In all studies carried out in
this work, the different cell lines were analyzed separately.
Ribonucleic Acid Isolation and cDNA Synthesis
Ribonucleic acid was isolated from primary stromal cultures
derived from three healthy corneal and three keratoconic
cultures using the RNeasy kit (Qiagen, Hilden, Germany) and
processed as previously described.26 Complementary DNA
synthesis was carried out using the High Capacity cDNA
Transcription Kit (Applied Biosystems, Foster City, CA, USA).
The reactions were performed and the products cleaned and
stored as previously described.26
Quantitative Real-Time PCR Reactions and Data
Analysis
Primer design (Supplementary Table S1), quantitative real-time
PCR (qRT-PCR) reactions, and analysis of amplimer products
was carried out as previously described.26 Actin was used as
the control gene to normalize individual gene expression.
The efficiencies of amplification were calculated using the
program LinRegPCR (http://www.gene-quantification.de/
download.html). The values of differential expression of the
genes were expressed as described previously.27 The nonpara-
metric Wilcoxon test was used for the statistical analysis of the
results. All analyses were performed using the program
Statistics for Windows (Statsoft, Inc., Tulsa, OK, USA).
Immunocytochemistry and Immunohistochemistry
Tissue sections from the central cornea, prepared as previously
described,28 were dewaxed, and rehydrated sections were
rinsed in PBS containing 1% Tween-20. Sections were heated in
high pH Envision FLEX target retrieval solution (Dako,
Glostrup, Denmark) at 658C for 20 minutes and then incubated
for 20 minutes at room temperature in the same solution.
Endogenous peroxidase activity and nonspecific binding were
blocked with 3% H2O2 and 33% fetal calf serum, respectively.
The sections were incubated overnight at 48C with 1:100
dilutions of the primary antibodies. Secondary antibodies were
also used at a 1:100 dilution, and 3-30 diaminobenzidine was
used as a chromogen. Finally, samples were counterstained
with hematoxylin, dehydrated, and mounted in Entellan
(Merck Millipore, Billerica, MA, USA). The sections were
studied and photographed under a light microscope (Eclipse
80i; Nikon Corporation, Tokyo, Japan).
Cell cultures were fixed in acetone at208C for 20 minutes,
washed with PBS, and incubated with primary antibodies as
described for the tissue sections. Fluorescent-conjugate sec-
ondary antibodies (Alexa 488 and Cy3) were used at 1:100
dilution and incubated with the fixed cells for 1 hour at room
temperature in a dark humid chamber. Finally, samples were
counterstained and mounted with 40,6-diamidino-2-phenyl-
indole (10 ng/mL; Sigma-Aldrich Corp., St. Louis, MO, USA)
diluted 1:1000 in fluoromount G (SouthernBiotech, Birming-
ham, AL, USA). Confocal immunofluorescence micrographs
were captured with a TCS-SP2-AOBS confocal microscope
(Leica Microsystems, Wetzlar, Germany).
We used the following antibodies: mouse monoclonal anti–
syndecan-1 (CD138) from DakoCytomation (Carpinteria, CA,
USA); rabbit polyclonal anti–syndecan-2 (M-140) and anti-
keratocan (H-50) from Santa Cruz Biotechnology (Santa Cruz,
CA, USA); mouse anti-endostatin monoclonal antibody and
rabbit anti–glypican-4 polyclonal antibody from Thermo Scien-
tific (Waltham, MA, USA); mouse anti-biglycan, rabbit anti-
lumican monoclonal antibodies, rabbit anti–glypican 6, and
rabbit anti–a-SMA polyclonal antibodies from Abcam (Cam-
bridge, UK); rabbit anti-osteoglycin polyclonal antibody from
USBiological (Salem, MA, USA); mouse anti-CS (CS-56) monoclo-
nal antibody from Sigma-Aldrich Corp.; and mouse anti-HS
epitopes 10E4, JM403 and 3G10 monoclonal antibodies from
amsbio (AMS Biotechnology, Abingdon, UK). Anti-mouse (sc-
2020) and anti-rabbit (sc-2004) secondary antibodies were also
from Santa Cruz Biotechnology. Alexa fluor 488–conjugated goat
anti-rabbit IgG was from Serotec (Oxford, UK), and CyTM3-
conjugated donkey anti-mouse antibody was from Jackson-
ImmunoResearch (Baltimore, MD, USA). Detection of HS
epitope 3G10 required previous digestion with heparinase III
(Sigma-Aldrich Corp.).
RESULTS
Differential Expression of Genes Encoding
Extracellular KS PGs
There are three KS PGs in the adult stromal ECM of the cornea:
keratocan, lumican, and osteoglycin. All three genes were
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underexpressed by the keratoconic primary stromal cultures.
For keratocan and lumican, the transcription levels were
approximately 50% of those in cultured cells from healthy
corneas and approximately 25% for osteoglycin (Figs. 1A, 1D).
With regard to the enzymes involved in the synthesis of the
GAG chains, no differences were apparent between the
cultured keratoconic and normal stromal cells in the transcript
levels of B4GALT4, which encodes a b-1,4-galactosyltransferase
(Fig. 1B). On the other hand, B3GNT7, which encodes a b-1,3-
N-acetylglucosaminyltransferase, was down-regulated more
than 50% in the cultured keratoconic cells (Figs. 1B, 1D).
Moreover, one of the two enzymes involved in the sulfation of
saccharide chains, CHST1, was up-regulated approximately 2.4-
fold in the cultured keratoconic stromal cells (Figs. 1C, 1D),
whereas no alterations were detected for CHST6.
Determination of KS PG expressions by immunohistochem-
istry also displayed a decrease in the levels of the three core
proteins (i.e., keratocan, lumican, and osteoglycin) in cultured
stromal cells of keratoconus corneas (Figs. 2B, 2D, 2F)
compared with cultured normal ones (Figs. 2A, 2C, 2E). The
same results were obtained when the analyses were carried out
using sections of keratoconus (Figs. 2H, 2J, 2L) and normal
corneas (Figs. 2G, 2I, 2K).
Differential Expression of Genes Encoding
Glycosyltransferases Involved in the Synthesis of
the Common Linkage Region of HS and CS Chains
The first step in the synthesis of CS/DS and HS chains requires
an array of glycosyltransferases (GTs) that generate a tetrasac-
charide glycan linker shared by both GAGs (Fig. 3).28 The
transcription of three of the genes involved in the biosynthesis
of the linker was altered in keratoconic stromal cells. The
mRNA levels of genes involved in the transfer of the first xylose
residue were deregulated, albeit in opposite directions: XYLT1
was decreased more than 3.5-fold, whereas XYLT2 was
increased by a similar magnitude (Figs. 4A, 4B). Moreover,
the transcription of B3GALT6, responsible for the transference
of the second galactose residue, increased approximately 2-fold
in the cultured pathologic cells. In addition, transcripts for only
one of the three isoforms involved the transfer of the first
glucuronate residue (GlcA), B3GAT3, could be detected,
although there was no significant difference between the
cultured keratoconic and normal cells (Fig. 4A). Moreover,
neither FAM20B nor PXYLP1, both involved in the control of
GAG chain formation through the phosphorylation and
dephosphorylation of the xylose residues, appeared differen-
tially transcribed.
Differential Expression of Genes Encoding
Extracellular CS PGs
The CS PGs decorin and biglycan are important in the corneal
stroma.29 In the cultured keratoconic cells, the expression of
decorin mRNA was not altered, but there was a 4-fold down-
regulation of biglycan (Figs. 5A, 5D). With regard to the
polymerization of CS chains, two GTs were significantly up-
regulated. CSGALNACT1, which is involved in the transfer of
the first N-acetyl-galactosamine residue (GalNAc), was in-
creased approximately 3-fold, and CHPF, a chondroitin
polymerizing factor, was increased approximately 7-fold (Figs.
5B, 5D).
Chondroitin sulfate/DS chains are modified to a lesser
extent than those of HS (Fig. 2).28 Two of the four genes
encoding sulfotransferases for the sulfation of C4 on the
GalNAc residue, CHST12 and -13, were up-regulated approx-
imately 2- and 6-fold, respectively, in the cultured keratoconic
cells (Figs. 5C, 5D). More important seems to be the change
that pathologic stromal cells undergo in the sulfation of GalNac
C6. The genes involved in this reaction (i.e., CHST15, -3, and
-7) were each overexpressed (Figs. 5C, 5D). For genes
encoding enzymes that act on the GlcA residue, there was
no difference in the expression of UST; however, there was a
greater than 2-fold down-regulation of DSE in the cultured
keratoconic cells (Figs. 5C, 5D).
Analysis of biglycan expression by immunohistochemistry
showed a reduction of the staining in cultured cells (Figs. 6A,
6B) and in sections of the keratoconic corneas (Figs. 6E, 6F),
indicating a correlation between the protein levels and the
transcription data. Immunostaining with anti-CS antibodies
showed a diffuse increase of staining in the pathologic corneas
(Figs. 6G, 6H). This increase was also detected in the cultured
cells (Figs. 6C, 6D).
FIGURE 1. Differential transcription of genes encoding the core
protein and the glycosaminoglycan chains of KS PGs by keratoconic
and normal cells in culture. (A–C) Relative transcript abundance of
mRNA. Relative abundance for cultured healthy stromal cells (gray
bars) and keratoconic stromal cells (black bars) are plotted on a log
scale for each gene assayed: (A) PG core proteins—keratocan (KERA),
lumican (LUM), and osteoglycin (OGN); (B) KS glycosyltransferase
genes—b-1,3-N-acetylglucosaminyltransferase 7 (B3GNT7) and b-1,4-
galactosyltransferase (B4GALT4); and (C) KS sulfation genes—Gal-6-
sulfotransferase (CHST1) and Gal-1-sulfotransferase (CHST6). (D)
Relative expression ratios (rER) of genes that were significantly
different between the keratoconic and normal cells in culture. Values
on the y-axis on a logarithmic scale. *P < 0.02; †P < 0.001. Error bars
denote SDs.
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FIGURE 2. Immunohistochemistry of KS PG core proteins. The two columns on the left show the results obtained using cultured corneal stromal
cells (Scale bar: 50 lm), whereas the two columns on the right show the results using corneal sections (Scale bar: 100 lm). (A, B, G, H) Keratocan.
(C, D, I, J) Lumican. (E, F, K, L) Osteoglycin. Arrows show the epithelium. Arrowheads show increased staining.
FIGURE 3. Genes involved in GAG biosynthesis. (A) Initiation and
elongation of HS and CS/DS chains; (B) KS disaccharide; (C) HS
disaccharide; and (D) CS disaccharide. The different genes for enzymes
that catalyze the specific reactions are highlighted in red.
FIGURE 4. Differential transcription of genes involved in the biosyn-
thesis of the tetrasaccharide glycan linker of HS and CS/DS saccharidic
chains. (A) Relative transcript abundance of mRNA. Relative abun-
dance for cultured healthy stromal cells (gray bars) and keratoconic
stromal cells (black bars) are plotted on a log scale for each gene
assayed. Xylosyltransferase I (XYLT1), xylosyltransferase II (XYLT2), b-
1,4-galactosyltransferase I (B4GALT7), b-1,3-galactosyltransferase II
(B3GALT6), b-1,3-glucuronyltransferase 3 (B3GAT3), b-1,3-glucuronyl-
transferase 1 (B3GAT1), b-1,3-glucuronyltransferase 2 (B3GAT2),
xylosylkinase (FAM20B), and 2-phosphoxylose phosphatase 1
(PXYLP1). (B) Relative expression ratio of genes that were significantly
different between the keratoconic and normal cells in culture. Values
on the y-axis are on a logarithmic scale. *P < 0.001. Error bars denote
SDs.
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Differential Expression of Genes Encoding
Cellular and Pericellular HS PGs
Heparan sulfate PGs occur both in cells and in the pericellular
matrix.30 The syndecan and the glypican gene families (SDC1-4
and GPC1-6) account for most cell surface HS PGs. In the
cultured keratoconic stromal cells, syndecan-1 and -2 were
underexpressed approximately 2- and 2.4-fold, respectively
(Figs. 7A, 7D). Within the glypican group, two isoforms, GPC4
and GPC6, were down-regulated in the cultured keratoconic
stromal cells approximately 50- and 2.6-fold, respectively (Figs.
7A, 7D). Other cell-associated HS PGs include betaglycan
(TGFBR3), CD44v3, and neuropilin-1 (NRP1) at the cell
membrane and serglycin, located intracellularly.8 None of
these showed any detectable differences between the cultured
keratoconic and normal stromal cells. Of the pericellular HS
PGs, only collagen XVIII was significantly up-regulated in the
cultured keratoconic cells, approximately 2-fold (Figs. 7A, 7D).
Only one of the enzymes involved in HS chain polymeriza-
tion, EXT2 (Fig. 3), was modified in the keratoconic cells, with
a more than 2-fold up-regulation (Figs. 7B, 7D). As the HS chain
polymerizes, it undergoes a series of modifications. The first
reaction involves N-deacetylation and N-sulfation of N-acetyl-
glucosamine residues, catalyzed by four different N-deacety-
lase/N-sulfotransferase (NDST) isoforms (NDST1-4).10,11
NDST2 was up-regulated approximately 2.8-fold in the
keratoconic corneas, whereas NDST3 was overexpressed more
FIGURE 5. Differential transcription of genes encoding the core protein and the glycosaminoglycan chains of CS PGs. (A–C) Relative abundance for
cultured healthy stromal cells (gray bars) and keratoconic stromal cells (black bars) are plotted on a log scale for each gene assayed. Genes that
displayed significant differences in their transcription levels are highlighted: (A) PG core proteins—biglycan (BGN) and decorin (DCN); (B) CS chain
polymerization genes—N-acetylgalactosaminyltransferase 1 (CSGALNACT1), N-acetylgalactosaminyltransferase 2 (CSGALNACT2), chondroitin
sulfate synthase 1 (CHSY1), chondroitin polymerizing factor (CHFP), and chondroitin sulfate synthase 3 (CHSY3); and (C) genes involved in the
modification of CS chains—chondroitin 4 sulfotransferase 11 (CHST11), chondroitin 4 sulfotransferase 12 (CHST12), chondroitin 4 sulfotransferase
13 (CHST13), chondroitin 4 sulfotransferase 14 (CHST14), N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase (CHST15), chondroitin 6
sulfotransferase 3 (CHST3), N-acetylglucosamine 6-O sulfotransferase 7 (CHST7), dermatan sulfate epimerase (DSE), and uronyl-2-sulfotransferase
(UST). (D) Relative expression ratio of genes that were significantly different between the keratoconic and normal cells in culture. Values on the y-
axis are on a logarithmic scale. *P ¼ 0.004; †P < 0.001. Error bars denote SDs.
FIGURE 6. Immunohistochemistry of CS PG core proteins and CS saccharidic chains. The two columns on the left show the results obtained using
cultured corneal stromal cells (Scale bar: 50 lm), whereas the two columns on the right show the results using corneal sections (Scale bar: 100
lm). (A, B, E, F) Biglycan. (C, D, G, H) Chondroitin sulfate. Arrows show the epithelium. Arrowheads show increased staining.
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than 4-fold (Figs. 7C, 7D). Interestingly, NDST4 was undetect-
able in normal cultured cells but was expressed at low levels in
the cultured keratoconic cells.
Further modifications of the HS chain include the epimeriza-
tion of GlcA into iduronate and the addition of sulfate groups at
C2, catalyzed by enzymes encoded by GLCE and HS2ST1. Both
genes were up-regulated approximately 2.5- and 2-fold, respec-
tively (Figs. 7C, 7D). The subsequent reaction involves the
sulfation of glucosamine residues at C6, catalyzed by 6-O-
sulfotransferase isoforms 1-3 (HS6ST1-3).10,11 Only transcripts
for HS6ST1 could be detected, and there were no significant
differences between the two groups. Interestingly, however, the
transcription of one of the two cell surface sulfatases that
remove GlcN-6S groups from specific regions, SULF2, was
down-regulated in the keratoconic corneas (Figs. 7C, 7D).
The last step in the synthesis involves the addition of a
sulfate group at C3 of glucosamine, catalyzed by 3-O-
sulfotransferases (HS3ST1-6).10,11 Significant differences in
expression were detected for HS3ST1, which was down-
regulated approximately 10-fold in the cultured keratoconic
cells, and for HS3ST2, which was barely detectable in the
cultured stromal cells from healthy corneas but strongly up-
regulated in cultured keratoconic cells (Figs. 7C, 7D).
Additionally, HS3ST6, despite having high variability between
the different cultured cells, was significantly up-regulated,
approximately 12.5-fold, in keratoconic cells (Figs. 7C, 7D).
The PG core proteins that displayed differential transcrip-
tions were analyzed by immunohistochemistry using cultured
cells and corneal sections. Both syndecan-1 and -2 had a weak
focal expression in the normal cultured stromal cells (Figs. 8A,
8C) and in the corneal stromas (Figs. 8K, 8M). This level of
expression was reduced in the cultured keratoconus samples
(Figs. 8B, 8D) and in the corneas (Figs. 8L, 8N), although the
low intensity of the signal made it difficult to detect in the
cornea. A diffuse reduction of glypican-4 expression was
present in the cultured keratoconic cells (Fig. 8F) and in the
corneas (Fig. 8P) compared with controls (Figs. 8E, 8O,
respectively). In contrast, glypican-6 was sharply labeled in
cultures of healthy stromal cells (Fig. 8G) and corneas (Fig.
8Q), but it was absent in keratoconic ones (Figs. 8H, 8R,
FIGURE 7. Differential transcription of genes encoding the core protein and the glycosaminoglycan chains of HS PGs. (A–C) Relative abundance for
cultured healthy stromal cells (gray bars) and keratoconic stromal cells (black bars) are plotted on a log scale for each gene assayed: (A) PG core
proteins—syndecan-1 (SYN1), syndecan-2 (SYN2), syndecan-3 (SYN3), syndecan-4 (SYN4), glypican-1 (GPC1), glypican-2 (GPC2), glypican-3
(GPC3), glypican-4 (GPC4), glypican-5 (GPC5), glypican-6 (GPC6), betaglycan (TGFBR3), CD44 isoform 3 (CD44v3), neuropilin 1 (NRP1), perlecan
(PRCAN), agrin (AGRN), collagen XVIII (COL18A1), and serglycin (SRGN); (B) HS chain polymerization genes—xylosylkinase (FAM20B), exostosin-
like glycosyltransferase 2 (EXTL2), exostosin-like glycosyltransferase 3 (EXTL3), exostosin glycosyltransferase 1 (EXT1), and exostosin
glycosyltransferase 2 (EXT2); and (C) genes involved in the modification of HS chains—N-deacetylase/N-sulfotransferase 1 (NDST1), N-
deacetylase/N-sulfotransferase 2 (NDST2); N-deacetylase/N-sulfotransferase 3 (NDST3), N-deacetylase/N-sulfotransferase 4 (NDST4), glucuronic acid
epimerase (GLCE), 2-O-sulfotransferase 1 (HS2ST1), 6-O-sulfotransferase 1 (HS6ST1), 6-O-sulfotransferase 2 (HS6ST2), 6-O-sulfotransferase 3
(HS6ST3), 3-O-sulfotransferase 1 (HS3ST1), 3-O-sulfotransferase 2 (HS3ST2), 3-O-sulfotransferase 3A1 (HS3ST3A1), 3-O-sulfotransferase
3B1(HS3ST3B1), 3-O-sulfotransferase 4 (HS3ST4), 3-O-sulfotransferase 5 (HS3ST5), 3-O-sulfotransferase 6 (HS3ST6), sulfatase 1 (SULF1), and
sulfatase 2 (SULF2). (D) Relative expression ratio of genes that were significantly different between the keratoconic and normal cells in culture.
Values on the y-axis are on a logarithmic scale. *P < 0.001; †P¼ 0.003. Error bars denote SDs.
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respectively). Furthermore, collagen immunostaining was
higher in the keratoconic stromal cultures (Fig. 8J) and corneas
(Fig. 8T) than in the controls (Figs. 8I, 8S), consistent with the
differential transcription data.
Because the results showed changes in the transcription
levels of several enzymes involved in HS biosynthesis, we
deduced that the levels and fine structure of HS chains could
also be altered. We therefore analyzed the distribution of
different HS epitopes in cultured cells and corneal sections
using immunohistochemistry. Immunodetection of 3G10
epitope was higher in both the keratoconic stromal cultures
(Fig. 9B) and corneas (Fig. 9H) than in the respective controls
(Figs. 9A, 9G). Epitope JM403 immunostaining was reduced in
the cultured keratoconus samples (Figs. 9C, 9D), although the
corneas displayed low intensity of the signal (Figs. 9I, 9J).
Finally, immunodetection of the 10E4 epitope was higher in
the keratoconic stromal cultures (Fig. 9F) and corneas (Fig. 9L)
than in their respective controls (Figs. 9E, 9K).
FIGURE 8. Immunohistochemistry of HS PG core proteins and HS saccharidic chains. The two columns on the left show the results obtained using
cultured corneal stromal cells (Scale bar: 50 lm), whereas the two columns on the right show the results using corneal sections (Scale bar: 100
lm). (A, B, K, L) Syndecan-1. (C, D, M, N) Syndecan-2. (E, F, O, P) Glypican-4. (G, H, Q, R) Glypican-6. (I, J, S, T) Collagen XVIII. Arrows show the
epithelium. Arrowheads show increased staining.
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DISCUSSION
In this study, we quantified the transcription levels of the genes
encoding all of the PGs and GAGs present in the cornea. This
analysis was conducted in cultured corneal stromal cells from
keratoconus patients compared with similarly prepared cells
from normal corneas. Although some keratocytes cultured in
media containing fetal bovine serum can become myofibro-
blasts,6 neither healthy nor keratoconic cells in our cultures
stained positively for a-SMA until the fifth passage, suggesting
that the stromal cell phenotype remained stable through at
least four passages. The expression products of the genes that
displayed transcription changes, including core proteins and
GAG chains, were analyzed by immunohistochemistry in
cultured cells and in paraffin-embedded corneal sections for
in situ comparisons.
Keratan sulfate is the major GAG in the cornea, and the
expression of the three core proteins to which it is complexed
(i.e., keratocan, lumican, and osteoglycin) was down-regulated
in cell cultures derived from keratoconic corneas and in the
corneas themselves as shown by immunohistochemistry. This
decrease has also been described previously in some proteo-
mic studies.1 It is consistent with the thinning and ectasia of
the cornea due to ECM degradation that itself may be due to
the transcriptional down-regulation of core protein produc-
tion.3 Notwithstanding, some studies have detected increased
levels of certain KS PGs in keratoconus,31 probably due to
methodologic differences in the analysis.32 Interestingly,
keratocan and lumican have been described to strongly inhibit
collagen cross-linking, a clinical treatment that targets the
stroma in progressive keratoconus.33
Chondroitin sulfate/DS are present mainly in the corneal
stroma as part of decorin and biglycan, although some HS PGs
may also carry them.34,35 In this study, biglycan was down-
regulated, as also found in previous studies,20 and although,
decorin mRNA levels remained unaltered here, other works
have described increased31 or decreased3 levels in keratoco-
nus.
With regard to the synthesis of KS chains, there was a
decrease in mRNA levels of B3GNT7, along with an increase in
CHST1, suggesting the existence of alterations in the chains
that affect both the extension and the sulfation of the
polysaccharide (Fig. 3). Although there are no previous studies
specifically focusing on the transcript levels of these genes, the
changes in B3GNT7 and CHST1 expression could be related to
previously reported changes in the KS in keratoconus.19,22,36
For CS, there were different alterations that affect the
polymerization and the chemical modification of the chains.
The initiation of CS chain polymerization is shared with the
synthesis of HS and involves the formation of a tetrasaccharide
linkage. The mRNA levels of the two genes involved in the
transfer of the xylose residue, XYLT1 and XYLT2, displayed
opposite alterations in the cultured keratoconic cells. The two
xylosyltransferases encoded by these genes differ in their
catalytic efficiency and expression patterns,37 and modulation
of their expressions is a regulator of GAG synthesis in some
pathologies.38 Moreover, B3GALT6, CSGALNACT1, and CHPF,
which encode, respectively, the transferase for the second
FIGURE 9. Immunohistochemistry of HS saccharidic chains. The two columns on the left show the results obtained using cultured corneal stromal
cells (Scale bar: 50 lm), whereas the two columns on the right show the results using corneal sections (Scale bar: 100 lm). (A, B, G, H) Epitope
3G10 (neo-epitope generated by digesting HS with heparinases). (C, D, I, J) Epitope JM403 (includes N-unsubstituted glucosamine residues). (E, F,
K, L) Epitope 10E4 (includes N-sulfated glucosamine residues). Arrows show the epithelium. Arrowheads show increased staining.
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galactose residue of the linker, the transferase that directs the
pathway toward CS synthesis, and a chondroitin polymerizing
factor, were all increased in the cultured keratoconic cells.
The CS backbone can be chemically modified in different
ways. The GalNAc residue can be sulfated at C4 or at C6, and
the uronic acid residue can be epimerized and sulfated at C2.
Transcription of the gene encoding the epimerase (DSE) was
down-regulated, which could affect the conversion of CS into
its steroisomer DS. Moreover, the three genes involved in C6
sulfation were overexpressed, as were two of the four genes
implicated in C4 sulfation. Interestingly, 4-O-sulfation has been
related to the control of the CS chain length because
cooperation between the enzymes encoded by CSGALNACT1
and CHST12 increases the number of CS chains.39 Both genes
were overexpressed in the cultured keratoconic cells.
Taken together, these results, for the first time, provide
evidence that keratoconic cells possess modified CS chains.
These changes affect expression levels and epimerization and
sulfation patterns. In support of these data, immunochemical
detection of the CS chains was increased in cell cultures and in
corneal sections from keratoconic corneas.
Small leucine-rich PGs are essential to maintain the corneal
structure, because they interact with collagen fibrils via their
protein cores. They also extend the GAG chains, interacting
with other GAG chains; thus, they organize the matrix and
preserve corneal transparency.40 Making stable antiparallel
connections between GAG chains by means of noncovalent
bonds requires domains that are long enough and is dependent
on structural features like epimerization and sulfation.40
Additionally, positively charged ions drawn by the charges on
the GAG chains may create local concentration gradients that
attract water molecules that participate in the control of
corneal structure.40 Therefore, the alterations described may
constitute the molecular basis for some of the features of
keratoconus such as changes in collagen fibril orientation and
corneal clouding.2
At the cell surface or in the pericellular matrix, HS PGs are
the most prevalent molecules, and although it has been
suggested that they are required for maintaining corneal
homeostasis,41,42 there are no previous studies we are aware
of which focus on them in keratoconus.8 HS PGs are
ubiquitous in tissues and mediate a variety of normal and
pathologic functions.10,11,43 Two gene families, syndecans and
glypicans, account for most cell surface HS PGs.30 In our study,
mRNA levels of syndecan-1 and -2 and glypican-4 and -6 were
down-regulated in cultured keratoconic cells, whereas tran-
scripts for other cell-associated HS PGs did not appear to suffer
any alteration. In contrast, collagen XVIII mRNA and protein,
mainly located at the pericellular matrix, were up-regulated.
Analysis of the transcription levels of the GTs involved in
the polymerization of the saccharidic chain showed up-
regulation for only EXT2. However, 50% of the genes
responsible for the HS fine structure displayed extensive
alterations. NDSTs are essential for the creation of sulfated
functional S-domains,10,11 and the transcription of NDST2, -3,
and -4 was increased in cultured keratoconic cells. Notably,
NDST3 and NDST4 are expressed primarily during embryonic
development and in some pathologic conditions.26,44 Epime-
rization and C2 sulfation of uronic acid residues are up-
regulated, as well as sulfation at C6 of glucosamine due to
under expression of the endosulfatase SULF2. Interestingly, the
transcription of three genes responsible for C3 sulfation,
HS3ST1, -2, and -6, involved in the formation of rare HS motifs
that interact in a selective manner with protein ligands,45
experienced specific alterations.
Analysis of the HS structure by immunohistochemistry
showed that in both keratoconic stromal cultures and corneas,
the expression of epitopes 3G10 and 10E4 increased, whereas
the epitope JM403 decreased in the cultured cells and
appeared weakly expressed in the corneas. 3G10 is a neo-
epitope generated by digestion with heparinase III, which
includes a desaturated uronate residue,46 10E4 is a native HS
epitope that includes N-sulfated glucosamine residues,46 and
the JM403 epitope includes N-unsubstituted glucosamine
residues.47 These data therefore suggest the existence of an
increase in heparan sulfate chains and their levels of sulfation.
Collectively, these results suggest that HS PGs undergo
significant changes in the cells of the keratoconic corneal
stroma. These changes could affect specific core proteins,
mainly located on the cell surfaces, as well as the HS chains.
The mechanism of action of HS includes specific, noncovalent
interaction with many different ligands.11 Through this variety
of interactions, HS PGs control many physiological functions.11
The observed differences can constitute the basis for the
abnormalities described in stromal keratocytes,48 as well as
affect the interactions between keratocytes and matrix
components that contribute to the regulation of stromal
matrix assembly.49
CONCLUSIONS
In summary, analysis of differential transcription of the genes
involved in the biosynthesis of PGs in cultured keratoconic
stromal cells identified important changes affecting both core
proteins and GAG chains. The changes were in genes that
regulate the polymerization of the chains and the modifications
by epimerization, N-sulfation, and O-sulfation. Interestingly,
analyses of the proteomic and gene expression patterns of
keratoconic corneas have detected the deregulation of several
signal molecules that function through specific interactions
with HS PGs.1,30 These data suggest that a relationship exists
between the alteration in the expression of ligands and their
receptors during the development of keratoconus.
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